SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891836-00-000470
Filing Date
2000-06-27
Accepted
2000-06-27 00:00:00
Documents
2
Group Members
ANDREW H. TISCHDANIEL R. TISCHFELIX J. BAKERFOUR PARTNERSJAMES S. TISCHJULIAN C. BAKERTHOMAS J. TISCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D, AMENDMENT NO. 2 0001.txt SC 13D/A 32642
2 AGREEMENT RE JOINT FILING OF STATEMENT 0002.txt EX-4 1684
  Complete submission text file 0000891836-00-000470.txt   36872
Mailing Address 10650E HILLSDALE BLVD SUITE 418 FORSTER CITY CA 94404
Business Address 349 OYSTER POINT BLVD SUITE 200 S SAN FRANCISCO CA 94404 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45279 | Film No.: 661539
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O BARRY L BLOOM 667 MADISON AVENUE NEW YORK NY 10021 212-545-2930
FOUR PARTNERS (Filed by) CIK: 0000942714 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231